showing

Arrowhead Pharmaceuticals Announces Interim Clinical Data on RNAi-based Obesity Candidates Showing Weight Loss in Obese Patients with Diabetes and Improved Measures of Body Composition

PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company’s investigational RNA interference (RNAi) therapeutics being developed…

Read more

Hazleton Standard Speakers Powerful Women Conference Offers Advice on Healthy Living HAZLETON — A Zumba session featured women showing off their salsa moves in the aisles, followed by a cooking demonstration without salsa. …16 hours ago

Hazleton's Standard Speaker Powerful Women Conference Offers Advice on Healthy Living HAZLETON — A Zumba session features women showing off their salsa moves in the aisles, then watching a cooking…

Read more